U.S. Firm Acquires Novozymes Biopharma Sweden

13:28 PM | October 31, 2011 | Deepti Ramesh

Biopharmaceutical company Repligen (Waltham, MA) says it has signed a definitive agreement to acquire Novozymes Biopharma Sweden (Lund, Sweden), a business of Novozymes (Bagsvaerd, Denmark), for €17...